HK1232154A1 - 預防或治療感音神經性耳聾或耳鳴的包括富含血小板的血漿的藥物組合物及其使用方法 - Google Patents

預防或治療感音神經性耳聾或耳鳴的包括富含血小板的血漿的藥物組合物及其使用方法

Info

Publication number
HK1232154A1
HK1232154A1 HK17105937.6A HK17105937A HK1232154A1 HK 1232154 A1 HK1232154 A1 HK 1232154A1 HK 17105937 A HK17105937 A HK 17105937A HK 1232154 A1 HK1232154 A1 HK 1232154A1
Authority
HK
Hong Kong
Prior art keywords
preventing
pharmaceutical composition
same
hearing loss
rich plasma
Prior art date
Application number
HK17105937.6A
Other languages
English (en)
Inventor
沈敏輔
Original Assignee
Shim Min Bo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shim Min Bo filed Critical Shim Min Bo
Publication of HK1232154A1 publication Critical patent/HK1232154A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK17105937.6A 2015-08-27 2017-06-14 預防或治療感音神經性耳聾或耳鳴的包括富含血小板的血漿的藥物組合物及其使用方法 HK1232154A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150121038 2015-08-27
KR1020160057806A KR101738815B1 (ko) 2015-08-27 2016-05-11 혈소판 풍부 혈장을 포함하는 감각신경성 난청 또는 이명을 예방 또는 치료하기 위한 약학적 조성물 및 이를 이용한 방법

Publications (1)

Publication Number Publication Date
HK1232154A1 true HK1232154A1 (zh) 2018-01-05

Family

ID=58404034

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17105937.6A HK1232154A1 (zh) 2015-08-27 2017-06-14 預防或治療感音神經性耳聾或耳鳴的包括富含血小板的血漿的藥物組合物及其使用方法

Country Status (3)

Country Link
KR (1) KR101738815B1 (zh)
HK (1) HK1232154A1 (zh)
RU (2) RU2657828C2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190019707A (ko) 2017-08-18 2019-02-27 한림대학교 산학협력단 프로테오믹스 기법을 이용한 혈소판 풍부 혈장 내의 조직치유 관련 단백질 분류방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
RU2008109703A (ru) * 2008-03-11 2009-09-20 Федор Вячеславович Семенов (RU) Способ герметизации предверия лабиринта в барабанной полости поршневой стапедопластике
US20120171161A1 (en) * 2010-12-30 2012-07-05 Sascha Abramson Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
EP2994147A4 (en) 2013-05-10 2017-03-08 Cell-Innovations IP Pty Ltd Compositions and methods for the treatment of tinnitus

Also Published As

Publication number Publication date
RU2657828C2 (ru) 2018-06-15
RU2016134793A3 (zh) 2018-03-01
KR20170026092A (ko) 2017-03-08
RU2720511C2 (ru) 2020-04-30
KR101738815B1 (ko) 2017-05-23
RU2018110570A (ru) 2019-02-28
RU2018110570A3 (zh) 2019-02-28
RU2016134793A (ru) 2018-03-01

Similar Documents

Publication Publication Date Title
EP3334354A4 (en) SYSTEM AND METHOD FOR IMPLANT INSTALLATION
HK1249013A1 (zh) 用於預防聽覺損傷的肽及其包含該肽的組合物
EP3328333A4 (en) SYSTEMS AND METHODS FOR CORNEAL IMPLANTS
EP3250157A4 (en) Modular endo-aortic device and method of using the same
EP3562529A4 (en) APPARATUS AND METHOD FOR INJECTING MEDICINES
EP3167959A4 (en) Safety cabinet and method for decontaminating safety cabinet
HK1246292A1 (zh) 1，3，5-三嗪衍生物及其使用方法
IL266454B (en) Implant and method of creating the implant
HK1243997B (zh) Kv1．3抑制劑及其醫學應用
EP3359663A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A COMPLEMENT-MEDIATED DISEASE
EP3512524A4 (en) METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
HK1249515A1 (zh) 預防和治療聽力損失的方法和組合物
EP3681508A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF VIRAL INFECTION
EP3556382A4 (en) METHOD OF PREVENTION AND TREATMENT OF SKIN FIBROSIS
FI3248597T3 (fi) Terapeuttinen aine sensorineuraaliseen kuulonmenetykseen
EP3556381A4 (en) MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND ITS USES
EP3636281C0 (en) METHOD FOR TREATING DEPRESSION AND PHARMACEUTICAL COMPOSITION
EP3675813A4 (en) METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS
EP3400008A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS B
EP3263109A4 (en) Drug for preventing and/or treating dementia
EP3139744A4 (en) Methods and compositions for treating and preventing tinnitus
EP3537972C0 (en) CHEMICAL-PHYSICAL SYSTEM FOR TREATING TINNITUS
HK1232154A1 (zh) 預防或治療感音神經性耳聾或耳鳴的包括富含血小板的血漿的藥物組合物及其使用方法
EP3395355A4 (en) METHOD FOR PREVENTING AND TREATING CERVICAL EROSION
EP3302684A4 (en) METHOD AND DEVICES FOR TREATING THE CORNEA